secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001193125-25-237998
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar posts updated corporate presentation; no financial or clinical data in filing
--------------------------------------------------------------------------------

- The 8-K filed on Oct 14, 2025, indicates an updated slide deck was posted on the company website.
- No numerical data, pipeline updates, or financial guidance were included in the filing text.
- The slide presentation (Exhibit 99.1) is referenced but its content is not available for review.
- Investors are directed to the company website for the full presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525237998/0001193125-25-237998-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525237998/lrmr-20251014.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-237998

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer